MACROGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
MACROGENICS, INC. (MGNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 2.98 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-08-14
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2026-06-30 was 213.75K shares, a 35.65% decline year-over-year.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2026-03-31 was 2.76M shares, a 56.82% increase year-over-year.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-12-31 was 199.60K shares, a 452.14% increase year-over-year.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-09-30 was 781.90K shares, a 1579.70% increase year-over-year.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 3.07M shares, a 54.80% increase from fiscal 2024.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 1.99M shares, a 41.02% decline from fiscal 2023.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 3.37M shares, a 20.49% increase from fiscal 2022.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 2.79M shares, a 43.95% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2026-06-30 | 213.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 2.98M shares 10-Q · filed 2026-08-14 | 3.17M shares derived: sum of 3 quarters · filed 2026-08-14 | 3.96M shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 2.76M shares 10-Q · filed 2026-05-13 | 2.96M shares derived: sum of 2 quarters · filed 2026-05-13 | 3.74M shares derived: sum of 3 quarters · filed 2026-05-13 | 4.08M shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 199.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 981.50K shares derived: sum of 2 quarters · filed 2026-03-09 | 1.31M shares derived: sum of 3 quarters · filed 2026-03-09 | 3.07M shares 10-K · filed 2026-03-09 |
| 2025-09-30 | 781.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 1.11M shares derived: sum of 2 quarters · filed 2025-11-12 | 2.87M shares 10-Q · filed 2025-11-12 | 2.91M shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 332.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 2.09M shares 10-Q · filed 2025-08-14 | 2.13M shares derived: sum of 3 quarters · filed 2025-08-14 | 2.18M shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 1.76M shares 10-Q · filed 2025-05-13 | 1.80M shares derived: sum of 2 quarters · filed 2025-05-13 | 1.84M shares derived: sum of 3 quarters · filed 2025-05-13 | 2.09M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 36.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 82.70K shares derived: sum of 2 quarters · filed 2025-03-20 | 331.63K shares derived: sum of 3 quarters · filed 2025-03-20 | 1.99M shares 10-K · filed 2025-03-20 |
| 2024-09-30 | 46.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | 295.48K shares derived: sum of 2 quarters · filed 2024-11-05 | 1.95M shares 10-Q · filed 2024-11-05 | 2.05M shares derived: sum of 4 quarters · filed 2024-11-05 |
| 2024-06-30 | 248.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 1.90M shares 10-Q · filed 2024-08-06 | 2.00M shares derived: sum of 3 quarters · filed 2024-08-06 | 2.09M shares derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | 1.65M shares 10-Q · filed 2024-05-09 | 1.75M shares derived: sum of 2 quarters · filed 2024-05-09 | 1.84M shares derived: sum of 3 quarters · filed 2024-05-09 | 2.11M shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 100.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 189.95K shares derived: sum of 2 quarters · filed 2024-03-07 | 453.37K shares derived: sum of 3 quarters · filed 2024-03-07 | 3.37M shares 10-K · filed 2024-03-07 |
| 2023-09-30 | 89.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 353.32K shares derived: sum of 2 quarters · filed 2023-11-06 | 3.27M shares 10-Q · filed 2023-11-06 | 3.33M shares derived: sum of 4 quarters · filed 2023-11-06 |
| 2023-06-30 | 263.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 3.18M shares 10-Q · filed 2023-08-09 | 3.24M shares derived: sum of 3 quarters · filed 2023-08-09 | 3.29M shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 2.91M shares 10-Q · filed 2023-05-09 | 2.98M shares derived: sum of 2 quarters · filed 2023-05-09 | 3.02M shares derived: sum of 3 quarters · filed 2023-05-09 | 3.36M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 64.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 109.80K shares derived: sum of 2 quarters · filed 2023-03-15 | 445.80K shares derived: sum of 3 quarters · filed 2023-03-15 | 2.79M shares 10-K · filed 2023-03-15 |
| 2022-09-30 | 45.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 381.40K shares derived: sum of 2 quarters · filed 2022-11-03 | 2.73M shares 10-Q · filed 2022-11-03 | 2.76M shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 336.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 2.69M shares 10-Q · filed 2022-08-08 | 2.71M shares derived: sum of 3 quarters · filed 2022-08-08 | 2.84M shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 2.35M shares 10-Q · filed 2022-05-03 | 2.38M shares derived: sum of 2 quarters · filed 2022-05-03 | 2.50M shares derived: sum of 3 quarters · filed 2022-05-03 | 2.74M shares derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-12-31 | 26.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 151.43K shares derived: sum of 2 quarters · filed 2022-02-24 | 385.88K shares derived: sum of 3 quarters · filed 2022-02-24 | 1.94M shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 124.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 359.05K shares derived: sum of 2 quarters · filed 2021-11-02 | 1.91M shares 10-Q · filed 2021-11-02 | 1.95M shares derived: sum of 4 quarters · filed 2021-11-02 |
| 2021-06-30 | 234.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | 1.79M shares 10-Q · filed 2021-07-29 | 1.83M shares derived: sum of 3 quarters · filed 2021-07-29 | 2.09M shares derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-03-31 | 1.56M shares 10-Q · filed 2021-04-29 | 1.59M shares derived: sum of 2 quarters · filed 2021-04-29 | 1.86M shares derived: sum of 3 quarters · filed 2021-04-29 | 2.00M shares derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | 35.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 303.70K shares derived: sum of 2 quarters · filed 2021-02-25 | 447.70K shares derived: sum of 3 quarters · filed 2021-02-25 | 1.85M shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 268.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 412.65K shares derived: sum of 2 quarters · filed 2020-11-04 | 1.82M shares 10-Q · filed 2020-11-04 | 1.38M shares derived: sum of 4 quarters · filed 2020-11-04 |
| 2020-06-30 | 144.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | 1.55M shares 10-Q · filed 2020-07-31 | 1.11M shares derived: sum of 3 quarters · filed 2020-07-31 | 1.70M shares derived: sum of 4 quarters · filed 2020-07-31 |
| 2020-03-31 | 1.40M shares 10-Q · filed 2020-05-05 | 965.63K shares derived: sum of 2 quarters · filed 2020-05-05 | 1.55M shares derived: sum of 3 quarters · filed 2020-05-05 | 1.72M shares derived: sum of 4 quarters · filed 2020-05-05 |
| 2019-12-31 | -438.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 150.13K shares derived: sum of 2 quarters · filed 2020-02-25 | 318.75K shares derived: sum of 3 quarters · filed 2020-02-25 | 1.95M shares 10-K · filed 2020-02-25 |
| 2019-09-30 | 588.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 756.75K shares derived: sum of 2 quarters · filed 2019-11-06 | 2.38M shares 10-Q · filed 2019-11-06 | 2.42M shares derived: sum of 4 quarters · filed 2019-11-06 |
| 2019-06-30 | 168.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | 1.80M shares 10-Q · filed 2019-07-31 | 1.84M shares derived: sum of 3 quarters · filed 2019-07-31 | 1.90M shares derived: sum of 4 quarters · filed 2019-07-31 |
| 2019-03-31 | 1.63M shares 10-Q · filed 2019-05-01 | 1.67M shares derived: sum of 2 quarters · filed 2019-05-01 | 1.73M shares derived: sum of 3 quarters · filed 2019-05-01 | 1.86M shares derived: sum of 4 quarters · filed 2019-05-01 |
| 2018-12-31 | 39.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 106.33K shares derived: sum of 2 quarters · filed 2019-02-26 | 230.97K shares derived: sum of 3 quarters · filed 2019-02-26 | 1.27M shares 10-K · filed 2019-02-26 |
| 2018-09-30 | 66.73K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 191.37K shares derived: sum of 2 quarters · filed 2018-11-07 | 1.23M shares 10-Q · filed 2018-11-07 | 1.26M shares derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | 124.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 1.16M shares 10-Q · filed 2018-08-07 | 1.19M shares derived: sum of 3 quarters · filed 2018-08-07 | 1.29M shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | 1.04M shares 10-Q · filed 2018-05-07 | 1.07M shares derived: sum of 2 quarters · filed 2018-05-07 | 1.16M shares derived: sum of 3 quarters · filed 2018-05-07 | 1.25M shares derived: sum of 4 quarters · filed 2018-05-07 |
| 2017-12-31 | 26.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 125.28K shares derived: sum of 2 quarters · filed 2018-02-27 | 215.16K shares derived: sum of 3 quarters · filed 2018-02-27 | 1.25M shares 10-K · filed 2018-02-27 |
| 2017-09-30 | 98.78K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 188.66K shares derived: sum of 2 quarters · filed 2017-11-08 | 1.22M shares 10-Q · filed 2017-11-08 | 1.27M shares derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | 89.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 1.12M shares 10-Q · filed 2017-08-02 | 1.17M shares derived: sum of 3 quarters · filed 2017-08-02 | 1.31M shares derived: sum of 4 quarters · filed 2017-08-02 |
| 2017-03-31 | 1.03M shares 10-Q · filed 2017-05-03 | 1.08M shares derived: sum of 2 quarters · filed 2017-05-03 | 1.22M shares derived: sum of 3 quarters · filed 2017-05-03 | 1.32M shares derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-12-31 | 53.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 193.78K shares derived: sum of 2 quarters · filed 2017-02-28 | 289.82K shares derived: sum of 3 quarters · filed 2017-02-28 | 399.95K shares 10-K · filed 2017-02-28 |
| 2016-09-30 | 140.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | 236.40K shares derived: sum of 2 quarters · filed 2016-11-02 | 346.52K shares 10-Q · filed 2016-11-02 | 1.13M shares derived: sum of 4 quarters · filed 2016-11-02 |
| 2016-06-30 | 96.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | 206.17K shares 10-Q · filed 2016-08-03 | 994.42K shares derived: sum of 3 quarters · filed 2016-08-03 | 1.06M shares derived: sum of 4 quarters · filed 2016-08-03 |
| 2016-03-31 | 110.13K shares 10-Q · filed 2016-05-04 | 898.37K shares derived: sum of 2 quarters · filed 2016-05-04 | 960.42K shares derived: sum of 3 quarters · filed 2016-05-04 | 1.06M shares derived: sum of 4 quarters · filed 2016-05-04 |
| 2015-12-31 | 788.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 850.29K shares derived: sum of 2 quarters · filed 2016-02-29 | 947.71K shares derived: sum of 3 quarters · filed 2016-02-29 | 987.68K shares 10-K · filed 2016-02-29 |
| 2015-09-30 | 62.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | 159.46K shares derived: sum of 2 quarters · filed 2015-11-04 | 199.44K shares 10-Q · filed 2015-11-04 | 896.41K shares derived: sum of 4 quarters · filed 2015-11-04 |
| 2015-06-30 | 97.41K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | 137.39K shares 10-Q · filed 2015-08-05 | 834.36K shares derived: sum of 3 quarters · filed 2015-08-05 | 877.96K shares derived: sum of 4 quarters · filed 2015-08-05 |
| 2015-03-31 | 39.98K shares 10-Q · filed 2015-05-06 | 736.95K shares derived: sum of 2 quarters · filed 2015-05-06 | 780.55K shares derived: sum of 3 quarters · filed 2015-05-06 | 986.39K shares derived: sum of 4 quarters · filed 2015-05-06 |
| 2014-12-31 | 696.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | 740.58K shares derived: sum of 2 quarters · filed 2015-03-03 | 946.42K shares derived: sum of 3 quarters · filed 2015-03-03 | 976.87K shares 10-K · filed 2015-03-03 |
| 2014-09-30 | 43.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 249.44K shares derived: sum of 2 quarters · filed 2014-11-12 | 279.89K shares 10-Q · filed 2014-11-12 | 899.81K shares derived: sum of 4 quarters · filed 2014-11-12 |
| 2014-06-30 | 205.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | 236.29K shares 10-Q · filed 2014-08-05 | 856.21K shares derived: sum of 3 quarters · filed 2014-08-05 | |
| 2014-03-31 | 30.45K shares 10-Q · filed 2014-05-06 | 650.37K shares derived: sum of 2 quarters · filed 2014-05-06 | ||
| 2013-12-31 | 619.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | 1.31M shares 10-K · filed 2014-03-20 | ||
| 2013-09-30 | 687.18K shares 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |